If you ask psychiatrists which antipsychotic is the most effective, most will give the same answer: clozapine. It is the only medication with FDA approval specifically for treatment-resistant schizophrenia, and the evidence behind it is overwhelming. It is also one of the most underused medications in modern psychiatry — for reasons that have very little to do with how well it works.
Clozapine is the most effective antipsychotic for people whose symptoms haven't responded to other medications, and the only one shown to reduce suicidal behaviour in schizophrenia.
What clozapine is
Clozapine (sold under the brand names Clozaril, Versacloz, and FazaClo) is an "atypical" or "second-generation" antipsychotic. It was discovered in the 1950s, briefly used in Europe, and largely withdrawn after a small number of patients died from a rare blood disorder called agranulocytosis. It was reintroduced in the United States in 1989 with mandatory blood monitoring — a system that today is called the Clozapine REMS Program.
How it works
Clozapine has a unique pharmacological profile. Unlike most antipsychotics, it has only weak D2 dopamine receptor blockade. Instead, it acts broadly across many neurotransmitter systems — serotonin (5-HT2A), histamine, alpha-adrenergic, muscarinic, and others. This broad action is one theory for why it works in cases where other medications fail, though no one fully understands its mechanism.
Who it's for
Clozapine is indicated for two main groups:
- Treatment-resistant schizophrenia — defined as inadequate response to two or more antipsychotic trials of adequate dose and duration. Roughly 30% of people with schizophrenia fall into this category, and clozapine works for the majority of them.
- Reduction of suicidal behaviour in schizophrenia or schizoaffective disorder — clozapine is the only antipsychotic with this indication, based on the InterSePT trial showing roughly 25% reduction in suicide attempts compared to olanzapine.
It is also used off-label for severe aggression in schizophrenia, Parkinson's-related psychosis, and treatment-resistant bipolar disorder.
How it's typically dosed
Starting doses are very low — usually 12.5 mg on day one — and titrated up slowly over 2 to 3 weeks to a typical target of 300 to 450 mg per day. Some patients require higher doses (up to 900 mg). The slow titration is essential to avoid orthostatic hypotension, sedation, and cardiac effects.
The blood monitoring requirement
Clozapine carries a small risk (roughly 0.4–1% over a lifetime) of severe neutropenia, where the white blood cell count drops to dangerous levels. To catch this early, every patient on clozapine in the US must:
- Have an absolute neutrophil count (ANC) checked weekly for the first 6 months
- Then every 2 weeks for the next 6 months
- Then monthly for the rest of treatment
The medication can only be dispensed if the most recent ANC is acceptable. This is a real burden — but it is also why deaths from clozapine-induced neutropenia have become extraordinarily rare.
Why it's underused
Despite being the most effective antipsychotic, clozapine is prescribed to only about 5% of people with schizophrenia in the US, compared to 20–30% in some European countries. The reasons:
- Mandatory blood monitoring is logistically demanding
- Side effect profile (especially weight gain, sedation, and drooling) is hard for patients
- Many clinicians lack training in clozapine management
- Concerns about rare but serious side effects (myocarditis, ileus)
The cost of underuse is substantial: people stay on less effective medications longer, experience more relapses and hospitalisations, and have worse long-term outcomes.
Common side effects
- Sedation — very common, often improves over weeks
- Weight gain — average ~10 kg over the first year (more than most antipsychotics)
- Hypersalivation (drooling) — particularly at night, can be managed
- Constipation — needs active management; can rarely become serious (ileus)
- Orthostatic hypotension — dizziness on standing, mainly during titration
- Tachycardia — usually mild but should be monitored
- Metabolic effects — diabetes risk, lipid changes
Serious but rare side effects
Fever, sore throat, or signs of infection (possible neutropenia); severe constipation or abdominal pain (possible ileus); chest pain or shortness of breath (possible myocarditis or cardiomyopathy); seizures.
What patients say
People who have benefited from clozapine often describe it as a categorical change — the first medication that genuinely quieted their voices or stopped their delusions. Many describe the daily blood draws of the first six months as worth it. Others find the side effects intolerable. The decision to start clozapine is always a careful weighing of risks and benefits with a psychiatrist.
If clozapine is being suggested
Questions worth asking your prescriber:
- Why now? What's been tried first?
- What dose target are we aiming for?
- How will the blood monitoring work practically — where, how often, who calls?
- What side effects should I watch for, and what should I do?
- Will I need a clozapine level (blood concentration) test, and when?
This article is for educational purposes only and is not medical advice. Information is summarised from publicly available FDA labelling. Always consult your prescribing clinician before starting, stopping, or changing any medication.